Connect with us

FbMagazine

How Will The New Normal Look Like for Businesses?

Published

on

Global economy corona virus

Not long ago, an interesting study came out of the U.K’s Guardian. Despite the country’s difficult battle to contain the spread of COVID-19, only 12% of respondents wanted to return to the “old normal” that we had before this blockbuster spring of 2020. This study confirms the world is embracing the idea of a “new normal” we keep hearing about. While the definition of this new term is still up in the air, it is certain that some things are here for the long-haul.

Here are four things that will likely be embodied in our new normal.

  1. Remote Working

The majority of leaders most likely never envisioned managing their employees online. Many people probably thought this was not even possible. With the power of Microsoft (NASDAQ: MSFT) Teams and Zoom Video Communications (NASDAQ: ZM), we realized that people can be as productive at home as they are at work. Maybe even more considering we have removed many distractions from our eight hours workday, such as the toll that the daily commute takes on people’s ability to function at their optimal capacity.

Back in March, Microsoft saw a 775% increase in the usage of its Cloud services, with Teams counting 44 million users on a daily basis that had spent 900 million in online meetings on a weekly basis. During the pandemic, Netscope reported that more than 58% of knowledge workers in North America shifted their thinking and showed they are flexible enough to adapt.

It is not at all unlikely that companies will consider a long-term remote working plan or at least a combination of office/remote work. Renting large offices is expensive, as well as their corresponding utility bills so this can also be a significant source of cost savings.

  1. Pressure to innovate

Master chocolatier Lindt & Sprüngli AG (OTC: LDSVF) was planning to launch its e-commerce platform in 2021. Due to being at risk of significant revenue reduction due to store closures, the online store was launched in only five days. In order to save their businesses, brands have responded more quickly than they perhaps ever thought possible. Another example of this speed has been shown by Zoom which had some much-publicized security issues. But it did not stop it from exponentially expanding its daily userbase from 10 million to 200 million. Moreover, it gained a hero status overnight as it has enabled businesses to keep the pace with these unprecedented times.

Now we know businesses can perform at “Flash Gordon” speed.

  1. Touchless interfaces – giving brands an identity in a sanitary manner

Once the surfaces we touch became ‘dangerous’, businesses started looking for touchless solutions that are more sanitary. One such solution is voice technology and it is in the perfect state of development to be applied at such a large scale.

Voice assistants such as Apple’s (NASDAQ: AAPL) Siri and Amazon’s (NASDAQ: AMZN) Alexa have gained an entirely new dimension with social distancing. Gartner predicts that by next year, one quarter of the workforce will use these voice-activated virtual assistants on a daily basis as opposed to last year’s 2%.

Even before the pandemic, many companies were looking for ways to enhance their brand value by giving it a sound signature. One example is BMW (OTC:BMWYY) which hired Hans Zimmer to compose a sound for its electric vehicle concept, the i4 sedan.

  1. Redefining CSR and actually taking action

There were always plenty of reasons to be a socially responsible business. Back in 2017, The Unilever Group (NYSE: UL) found that one third of consumers opt for brands that do good for the environment and the society. These days, nine in 10 millennials are willing to switch to a brand that complements their moral values.

The pandemic emphasized that being socially responsible is just the right thing to do. This time around, the wave was strong enough that it caused big names such as The Coca-Cola Company (NYSE: KO) and CVS Health Corporation (NYSE: CVS) to pause their ads from Facebook (NASDAQ: FB) as part of the “Stop Hate for Profit” campaign. Although this boycott didn’t hurt the powerful social media giant that much, the message is clear. The Guardian study even found that many are willing to pay higher taxes for a fairer and nicer society.

The new normal is “in the making”

We are now creating a new normal. The past several months have proven that many of us are adaptable and agile. The pandemic allowed us to tap into skills we never knew we had as well as ‘stop and smell the roses’, both of which can enhance both our productivity and quality of life simultaneously. Business leaders have a lot to think about as their businesses have a duty to help create a new society. A society that people want and need now more than ever.

The worst phrase you can say these days is: “We’ve always done it that way”. The way ahead is: “Unlearn. Relearn. Undo. Redo.” With some luck and by actually learning some important lessons so we can emerge wiser from this crisis, the new normal could be our best normal yet.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure . IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: contributors@iamnewswire.com

IAM Newswire

Latest posts by IAM Newswire (see all)

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

BenzingaEditorial

Vaccine Updates

Published

on

Corona Virus and the Stock Market

Besides saving lives and the global economy, we are expecting three things from the upcoming COVID-19 vaccine: safety, immunogenicity and efficacy. But we never had a 100 per cent efficacy when it comes to respiratory viruses, so anything between 50 and 100% will be the best we’ve got as the WHO believes everything above 50 per cent efficacy is acceptable. So, how far away are we from this goal?

Buoyed by positive results in its earlier studies, Johnson & Johnson (NYSE: JNJ) has now entered the final stage of clinical trials for its COVID-19 candidate. Although they started a couple of months behind others in the US, its trials will by far be largest with 60,000 enrolled participants.

The advantage of J&J candidate – one dose and no sub-zero storage temperatures

J&J’s vaccine is made with slightly different technology than others as it is modeled on its prior Ebola vaccine. It could result in considerable advantages over some of its competitors in terms of dosage and storage. But it’s up to Phase 3 trials that compare the effects of a vaccine with those of a placebo to determine if a single dose is indeed effective.

Disadvantages of Moderna and Pfizer candidates – significant logistics hurdle

Adenovirus vaccines must be kept refrigerated but not frozen, unlike the two front-runner vaccines, by Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE). These depend on bits of genetic material known as mRNA. Besides the freezing requirement that makes distribution problematic, there vaccines also need to be taken in two doses, a few weeks apart.

Side-effects

When participants received a dose more than double the strength of the current shot of Moderna vaccine, 20 per cent experienced significant adverse effects such as fever and severe headaches. AstraZeneca was forced to pause its study for the same reason. Although the trial resumed in the UK and elsewhere, the research remains on hold in the US.

Candidates – US

Johnson & Johnson is now the fourth company to begin large-scale clinical trials for a COVID-19 vaccine in the United States, behind Moderna, Pfizer/BioNTech (NASDAQ: BNTX) and AstraZeneca (NYSE: AZN). According to Anthony S. Fauci M.D., this is an unprecedented speed made possible by decades of progress in vaccine technology and a coordinated approach that expanded beyond the scientific community, supported by governments and industries.

Candidates- Global

Financial Times has reported that there is a total of more than 300 vaccine candidates, according to the World Health Organization. Less than half are being tested on humans. Only nine of those have reached phase 3 trails which is the final stage before possible implementation. One of the nine vaccines is UK’s Astrazaneca. Two of the most advanced US candidates come from pharmaceutical company Pfizer, in partnership with Germany’s BioNTech, and Moderna. Four vaccines are being produced in China by Sinovac Biotech and one in Russia by the Gamaleya Research Institute which just boarded the phase 3 train this month. Then, there are CanSino Biologics (OTC: CASBF) and Sinopharm (OTC: SHTDY), which has two different shots in development and one is being led by Johnson & Johnson. All nine have already signed purchase agreements with governments around the world.

Countries

According to data from Deutsche Bank, the UK has built the largest and most diversified vaccine portfolio, on a per-capita basis, having pre-ordered more than five doses per citizen spread across six leading vaccine candidates. It is closely followed by US, Canada and Japan.

When it comes to the overall spender, the US government’s Biomedical Advanced Research and Development Authority has distributed more than $10 billion in funding for vaccine candidates, either via direct financing or through vaccine procurement agreements.

Canada has allocated $1 billion to secure at least 154 million doses of a future vaccine, signing deals with Pfizer, Moderna Inc, Johnson & Johnson, and Novavax (NASDAQ: NVAX) and most recently, Sanofi (NASDAQ: SNY).

The goal

The stated objective of the AstraZeneca, Moderna, Pfizer/BioNTech and J&J vaccines is to prevent the life-endangering symptoms of Covid-19. Their goal is to prevent people being admitted to hospital, going to intensive care and dying, as summarized by Andrew Pollard, who is leading the AstraZeneca trials at Oxford university. But preventing an asymptomatic infection entirely is likely to be a much bigger hurdle. Given the growing chorus of experts warning that vaccines will only offer a temporary immunity, making subsequent shots just as important. Only Johnson and Johnson and CanSino Biologics Inc are aiming for single dose shots.

If successful, Johnson & Johnson expects the first doses to be up for emergency use authorization from the US FDA at the beginning of  next year, while on track to make a billion doses a year. If this is the case, it would greatly help efforts to curb the pandemic.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure . IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: contributors@iamnewswire.com

IAM Newswire

Latest posts by IAM Newswire (see all)

Continue Reading

BenzingaEditorial

Four Evolving Lighting Companies

Published

on

Solar Stocks and Corona Virus

To run their operations, companies need lighting – among other things. Moreover, this lighting has to be energy-efficient to give the world a shot at taking control over climate change. LED lighting market has been intensively growing over the last decade. Its strength is a direct consequence from energy efficiency regulations and reduced technology costs. An average building uses about 15% of its energy for lighting therefore the savings potential of LED lighting across the globe is immense. But, lighting has expanded beyond its traditional purpose of illumination to add additional value such as sustainability. Consequently, it has also become a highly competitive market. Below are four companies that are well-positioned to benefit from this growing trend.

Acuity Brands

Unfortunately, Acuity Brands Inc (NYSE:AYI), the parent company of Acuity Brands Lighting was among the S&P 500’s biggest fallers on Wednesday September 23. The stock experienced a 2.56% decline to $98.07. But this is not the bigger picture as widespread adoption of Far-UVC lighting could create a large retrofit revenue opportunity for this industrial technology company. It is better to wait for October 8th for the company to announce its fourth quarter results to get a better idea of this prominent company.

Acuity Brands provides lighting products for the whole range of applications: from commercial to residential. Their customers are electrical distributors, electric utilities, retail home improvement centers, and lighting showrooms. Their offerings include luminaires, lighting controls, lighting components, and integrated lighting systems that use a combination of light sources. The majority of the firms’ revenue is generated in the United States, but it has operations across Europe and Asia as well, counting 12,000 associates.

Orion Energy Systems Inc

Orion Energy Systems Inc (NASDAQ:OESX) is the provider of LED lighting systems while implementing IoT systems and providing ongoing maintenance service. When the company reported its FY2021 first quarter results, it revealed it secured a contract with a large speciality retailer. The company just announced that its CFO William T. “Bill” Hull, plans to retire in November following its second quarter results, so it is in for a new chapter this year.

Cree Inc

The stock of Cree Inc (NASDAQ:CREE) is soaring and is possibly approaching a major achievement in its business. It provides lighting-class LED for power and radio-frequency applications with an international presence spanning across the United States, China and Europe.  On June 28th 2020, the US$6.6 billion market-cap company posted a loss of US$191.7 million for its most recent financial year. Although its shareholders might be concerned after seeing the share price drop 13% in the last month, they have received really good returns over the last five years. In fact, the share price was 154% higher on September 23rd. To some, the recent pullback isn’t surprising after such a fast rise. But this does not change the fact that Cree has rewarded its shareholders with a total shareholder return of 22% during the last twelve months.

Energy Focus

Energy Focus Inc (NASDAQ:EFOI) recently won a $4.8 million indefinite-quantity contract to provide LED lighting to U.S. Navy for its demanding exterior shipboard use. LED lights use up to 80% less energy than traditional lighting, while meeting the required illumination levels for combat, and general operations.

Additionally, Energy Focus also reported that it has gained the right to serve all government agencies in the U.S. Its patent- pending EnFocus™ lighting control platform embodies the true spirit of “Triple Bottom Line” benefits:  financial, environmental, and health, while being affordable and accessible. In other words, EnFocus™ can enhance occupant well-being and maximize energy savings while being affordable and without increasing security risk. The beauty of its model is that it can span across industries.

Outlook

The global LED lighting market was estimated to be $67,714.7 million in 2019. This is an increase of 3.2% from 2018. Over the last two years, we have observed major players either selling a part of their business or being acquired by another company. Smart LEDs are wanted for the controllability they offer. Companies are going a step forward with circadian lighting that supports well-being. Leading lighting players are also working with healthcare facilities to accelerate the use of UVC LEDs to eliminate the threat of infection arising from contact. Horticultural lighting also did great in terms of demand during the past few years. To cut the story short, there will be many new chapters ahead when it comes to lighting.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure . IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: contributors@iamnewswire.com

IAM Newswire

Latest posts by IAM Newswire (see all)

Continue Reading

BenzingaEditorial

Tesla Battery Day Didn’t Live Up to Expectations

Published

on

Tesla Electric Vehicles

As expected, Elon Musk made some big announcements on Tesla’s (NASDAQ: TSLA) Battery Day event and a drive-in movie/shareholders meeting. What Musk teased to be a ‘very insane’ development turned out to be a revolutionary battery but news also included eliminating cobalt use, a new Plaid powertrain for the Model S and a new cathode plant.

Most importantly, with the new battery technology, Tesla now has a new goal: a $25,000 car. The Battery Day was expected to ease threats from Tesla’s upcoming competitors: Nikola (NASDAQ: NKLA), Rivian, Hercules and Atlis. Atlis just announced a partnership with innovative tonneau-cover producer Worksport (OTC: WKSP) to enhance its tech-advanced electric truck with the TerraVis solar-charging system.

The EV game is heating up as traditional automakers such as General Motors (NYSE: GM), Ford (NYSE: F) and Volkswagen (OTC: VWAGY) are also seriously upgrading their game for the electric era.

The key takeaway is that Musk aims to achieve a complete vertical integration and that would put Tesla ahead of any potential competitors.

Battery Cells to Improve Range

Tesla currently gets its batteries from Panasonic Corporation (OTC: PCRFY) but in-house production has been on Musk’s to-do list for quite a while. Back in 2018, Musk said Panasonic’s pace slowed down Tesla’s Model 3 and Model Y production. Tesla plans to manufacture its own batteries in the future. But, this battery will be “tabless” to improve the range and power of its vehicles. Being tabless means removing the tab that connects the cell and what is powering to make the battery up to six times more efficient and powerful by increasing the range by 16 percent. When it comes to range, every km counts.

Model S Plaid in 2021

The plaid powertrain also had its fair share of teases. But a plaid trim will cost more than other Tesla’s offerings as it is currently listed for $139,990. It will be available in its Model S but by the end of next year.

A New Cathode Plant

On its quest to reduce supply chain costs and simplify cathode production, Tesla will build a plant for its batteries. Although the location is unknown, Musk mentioned back in July that Tulsa, Oklahoma would be considered for future projects. It came second after Austin, Texas that Tesla chose for its next Gigafactory.

Eliminate Cobalt

Even though Tesla uses very little cobalt in its batteries, Musk already said in the past he wants to eliminate it entirely. Cobalt mining tends to violate human rights and it will become history for Tesla in the near-future.

A $25,000 EV

The final goal is to bring the selling price of Tesla’s models close enough to compete with that of traditional ICE vehicles so people can afford them. Reducing the cost of battery cells and packs is an essential step on this quest. But, this isn’t the first time Musk made this promise as back in 2018, he already said a $25,000 EV will be possible within three years.

Outlook – path towards affordability

Affordability is key to scale and Tesla has laid a clear path towards producing an affordable EV. But a battery prototype never appeared during the event and it remained unclear what has Tesla actually achieved. Elon Musk only delivered a promise of a revolutionary battery, but not the battery itself. Its specs appear to offer large performance gains in a few key areas. But several hundred investors sitting in their Teslas from a makeshift stage in the parking lot of the Tesla factory in Fremont, California, left without knowing how far has Tesla gone in realizing these upgrades. All EV players are promising revolutionary developments, but none of them has seen the light of the day yet. We don’t even know how well Tesla’s new cell scored at performance tests.

Meanwhile, traditional automakers have well-established systems, expertise and legacy. Tesla has yet to pass the test of time. Investors were underwhelmed by only hearing promises for developments that are far-off in the future. As a consequence, shares dropped 6.8% in the extended session.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure . IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: contributors@iamnewswire.com

IAM Newswire

Latest posts by IAM Newswire (see all)

Continue Reading
Advertisement

Submit an Article

Send us your details and the subject of your article and an IAM editor will be in touch with you shortly

Trending